Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |